MetaCap

Labcorp Holdings Inc. (LH)

NYSE: LHHealth CareMedical SpecialitiesUSD

367.13-1.75 (-0.47%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

LH stock chart

Technical analysis

Key statistics

All statistics
Market cap
$29.81B
EPS (TTM)
$12.20
Dividend yield
0.78% ($2.88)
Ex-dividend date
Aug 28, 2026
52-week range
245.00 – 375.10
Day range
366.38 – 372.21
Volume / Avg
890.42K / 744.44K
Beta
—

52-week range

$245.00$375.10

LH stock today

Labcorp (LH) closed at $367.13 on Nov 20, down 0.47% (-$1.75), versus the S&P 500's 3.70% decline. At this level, LH sits near the top of its 52-week range of $245.00 to $375.10: 2.1% below the high, set on Nov 12, 2026 and 49.8% above the low. LH is up 46.3% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 38.2%.

At 30.1x trailing earnings, Labcorp trades above the peer-group median of 25.7x. Its forward P/E of 18.7x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Labcorp pays an annual dividend of $2.88 per share, a 0.78% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Labcorp

Company profile

Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments.

Industry
Medical Specialities
CEO
Mr. Adam H. Schechter
Headquarters
Burlington, NC
Employees
71,000

Financial highlights

Full financials

In fiscal 2025, Labcorp generated $13.95 billion in revenue, up 7.2% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $876.5 million (+17.5% year over year), for a net margin of 6.3% versus a median of 10.8% in the prior 5 years. Gross margin was 28.8% (up from 27.9%) and operating margin 9.9%.

Labcorp annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2021FY 2021
Revenue$13.95B$13.01B$12.16B$11.86B$13.14B
Growth+7.25%+6.97%+2.51%-9.68%-6.03%
Net income$876.50M$746.00M$418.00M$1.28B$2.38B
EPS (diluted)$10.46$8.84$4.77$13.97$24.39

Analyst forecast

Forecast

Consensus (17 analysts)

buy

Avg. price target

$390.06+6.25%

  • Strong buy 2
  • Buy 11
  • Hold 4
  • Sell 0
  • Strong sell 0

Target range

Low $347.00High $420.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 28, 2026
EPS actual vs est.
$4.18 vs $4.65
Surprise
-10.11%

Dividends

Dividend history
Annual dividend
$2.88
Last payment
$0.72
Ex-dividend date
Aug 28, 2026

LH news

All LH news

Labcorp peers

Health Care sector
LH peer companies
CompanyPrice% ChgMarket capCompare
ILMNIllumina Inc.192.82-3.90%$29.15Bvs LH
DGXQuest Diagnostics Incorporated258.28-0.31%$28.42Bvs LH
CNCCentene Corporation63.78-2.74%$31.58Bvs LH
NTRANatera Inc.273.40-5.70%$39.64Bvs LH
GHGuardant Health Inc.145.83+0.16%$19.73Bvs LH
HUMHumana Inc.390.00+2.63%$46.84Bvs LH
MOHMolina Healthcare Inc198.39-2.43%$10.36Bvs LH
HSICHenry Schein Inc.83.52-1.51%$9.23Bvs LH

Indexes, lists and sector

Labcorp stock FAQ

What is Labcorp's stock price today?

LH last traded at $367.13 as of Nov 20, 4:00 PM EST, down 0.47% on the day. Prices are delayed at least 15 minutes.

Does Labcorp pay a dividend?

Yes. Labcorp pays $2.88 per share annually, a 0.78% yield. The most recent dividend of $0.72 had an ex-dividend date of Aug 28, 2026.

What is LH's P/E ratio?

LH trades at a trailing P/E ratio of 30.09 and a forward P/E of 18.73, compared with a median of 25.7 for its closest peers.

Is Labcorp in the S&P 500?

Yes. Labcorp (LH) is a constituent of the S&P 500 index.

Who is Labcorp's CEO?

Mr. Adam H. Schechter is the chief executive officer of Labcorp Holdings Inc., which has about 71,000 employees.

Has LH ever split its stock?

Yes. The most recent LH stock split was a 1164-for-1000 split on Jul 3, 2023, one of 4 splits on record.

What is the LH 52-week high?

The 52-week high for LH is $375.10 and the 52-week low is $245.00. The stock is currently 2.1% below its high.

Compare LH